Berkadia Investment Sales

Berkadia's investment sales group provides buy-side and sell-side advisory on the acquisition and disposition of commercial property, focused on multifamily housing, hotels and hospitality, land, medical and life sciences, seniors housing and healthcare, single-family rental and build-to-rent, and student housing.

Advisors work a national network that shares market and pricing intelligence, including recent experience with active buyers and new market entrants, alongside Berkadia's mortgage banking and servicing teams, so a sale and its financing can be run through the same firm. Institutional clients also get capitalization structures built around a single asset or a portfolio, and a strategic alliance with Knight Frank opens access to capital sources outside the United States.

Across 2024 and 2025 the group reported $30B in investment sales volume across 1,120+ transactions, and 1,890+ listings taken. Institutional-grade volume was $14.2B from 2023 to 2025, including $4.7B in 2025 at an average deal size of $73.4M; in 2024 it advised on 90 institutional-grade sales totalling more than $6 billion. It fields 180+ investment sales advisors across 50+ offices and reports an 8.1% multifamily investment sales market share at year-end 2025 per Real Capital Analytics.

Investment sales and real estate brokerage are conducted by Berkadia Real Estate Advisors LLC and Berkadia Real Estate Advisors Inc. Commissions are not published, and the investment sales page states a 2025 transaction volume that does not reconcile with the two-year figure on the institutional solutions page, so confirm the numbers with the team.